Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP: DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease / CLINICAL PERSPECTIVE
Semaglutide targets only the GLP-1 receptor and achieved 14.9% mean weight loss at 68 weeks in the STEP 1 trial
(2008) Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Eric Topol, kardiolog, ki vodi neprofitni raziskovalni intitut Scripps Research v San Diegu v Kaliforniji, je zdravila GLP-1 na portalu x nedavno oznail za najpomembneji preboj na podroju zdravil v zgodovini medicine.
The body doesnt readily convert N-Acetyl L-Tyrosine to Tyrosine